                     IN THE SUPREME COURT OF MISSISSIPPI

                                 NO. 2008-CA-01932-SCT

HERBERT LEE, JR.

v.

GLORIA THOMPSON AND DEBORAH DIXON


DATE OF JUDGMENT:                           01/31/2008
TRIAL JUDGE:                                HON. BOBBY BURT DELAUGHTER
COURT FROM WHICH APPEALED:                  HINDS COUNTY CIRCUIT COURT
ATTORNEY FOR APPELLANT:                     LEONARD McCLELLAN
ATTORNEY FOR APPELLEES:                     LANCE L. STEVENS
NATURE OF THE CASE:                         CIVIL - CONTRACT
DISPOSITION:                                ON DIRECT APPEAL: AFFIRMED AND
                                            REMANDED. ON CROSS-APPEAL:
                                            REVERSED AND REMANDED - 09/09/2010
MOTION FOR REHEARING FILED:
MANDATE ISSUED:


       BEFORE WALLER, C.J., LAMAR AND PIERCE, JJ.

       PIERCE, JUSTICE, FOR THE COURT:

¶1.    This appeal arises from the trial court’s grant of summary judgment in an action

between an attorney and his former clients. Gloria Thompson and Deborah Dixon sued

attorney Herbert Lee, Jr., who represented them in diet-drug litigation, for breach of contract,

tortious breach of contract, failure to accurately refund their portion of a multi-district

litigation fee, and under the theory of quantum meruit. The trial court granted partial

summary judgment to the plaintiffs and partial summary judgment to the defendant. Both

parties appeal.
                                                 FACTS

¶2.     Gloria Thompson and Deborah Dixon (collectively referred to as “the plaintiffs”)

hired attorney Herbert Lee, Jr., to represent them in diet-drug litigation (commonly referred

to as Fen/Phen claims) against the diet-drug manufacturer, American Home Products

(“AHP”). They were among thirteen plaintiffs who hired Lee to represent them in the diet

drug suit against AHP on a contingency-fee basis. The parties dispute whether the

contingency fee agreed to was forty percent or forty-five percent.

¶3.    The diet-drug lawsuit was filed on behalf of the thirteen plaintiffs in the Circuit Court

of Holmes County, Mississippi, and settled for an aggregate amount of approximately $32

million. As part of the settlement, a Multi District Litigation 1203 1 (“MDL 1203”) assessment

        1
         MDL 1203: United States Courts' Multidistrict Litigation, Action No. 1203, In Re: Diet Drugs
“consolidates, for pretrial purposes, all federal litigation relating to use of the diet drugs Phentermine,
Fenfluramine, and Dexfenfluramine. Collectively, these drugs are commonly referred to as ‘Fen/Phen’.”
www.fenphen1203.com. “Any action pending in any state court which relates to the personal injuries
allegedly caused by the [Fen/Phen drugs] is eligible for State-Federal coordination.” MDL 1203 Pretrial
Order No. 467. (Feb. 10, 1999). The history of MDL 1203 is as follows:

                 From 1989 through September, 1997, Wyeth marketed and sold two prescription
        drugs for weight loss in the United States under the brand names Pondimin (fenfluramine)
        and Redux (dexfenfluramine) (hereinafter “diet drugs”). Beginning in 1992, physicians
        commonly prescribed Pondimin in combination with phentermine, another prescription diet
        drug. Phentermine was and still is distributed and sold under several different brand names.
        The combination of Pondimin with phentermine was often referred to as “fen-phen.” Wyeth
        had significant sales of both Pondimin and Redux in the mid-1990's. From January, 1995
        until mid-September, 1997, approximately four million persons in the United States took
        Pondimin. Similarly, from June, 1996 through September, 1997, two million people in this
        country used Redux.
                 During the period from March to August, 1997 the Mayo Clinic in Rochester,
        Minnesota observed and reported an association between the use of fenfluramine and/or
        dexfenfluramine and valvular heart disease (“VHD”). On September 15, 1997, Wyeth and
        the Food and Drug Administration (“FDA”) announced that there would be no further sales
        of Pondimin and Redux in the United States. Since that time, epidemiological studies have
        established a causal relationship between fenfluramine and dexfenfluramine and VHD. These
        studies have also determined that fenfluramine and dexfenfluramine cause a fatal but rare
        disease known as primary pulmonary hypertension (“PPH”).
                 A tidal wave of litigation followed the withdrawal of Pondimin and Redux.
        Individuals who had ingested diet drugs filed lawsuits and class actions in federal and state

                                                     2
fee of six percent of the total settlement was withheld and sent to the MDL 1203 Fee and Cost

Account. The six percent fee resulted from Lee contracting with the Plaintiffs’ Management

Committee (“PMC”) of MDL 1203 to provide he and his clients certain “common benefit”

discovery material.

¶4.    Both plaintiffs signed disclosure sheets documenting the disbursal of funds prior to

receiving their portion of the settlement. They allege they were coerced by Lee into signing

the disclosure sheet. Thompson received the largest settlement award of Lee’s thirteen diet-




       courts against Wyeth and other defendants, including manufacturers, distributors,
       weight-loss clinics, pharmacies and physicians. On December 10, 1997, the Judicial Panel
       on Multidistrict Litigation (the “JPML”) designated the United States District Court for the
       Eastern District of Pennsylvania as the transferee court for IN RE: DIET DRUGS
       (PHENTERMINE/FENFLURAMINE/DEXFENFLURAMINE) PRODUCTS LIABILITY
       LITIGATION, MDL 1203 (“MDL 1203”). See 28 U.S.C. § 1407. All cases filed in the
       federal judicial system were subsequently transferred to the Eastern District of Pennsylvania
       for coordinated and consolidated pretrial proceedings. To date, at least 105,000 plaintiffs
       have filed lawsuits, over 130 class actions were transferred to the MDL and the claims of
       more than 35,000 plaintiffs have been transferred by the JPM L to [the Eastern District of
       Pennsylvania].
                 Shortly after the first transfer of cases to MDL 1203, the court established the
       Plaintiffs' Management Committee (“PMC”) to oversee the coordinated and consolidated
       pretrial proceedings and to conduct discovery of widespread applicability on behalf of
       plaintiffs in MDL 1203. . . .As part of its duties and responsibilities, the PMC assisted and
       continues to assist all plaintiffs in MDL 1203 and state-federal coordinated proceedings by
       appearing frequently before [the United States District Court for the Eastern District of
       Pennsylvania], attending regular status conferences held by the Special Discovery Master,
       . . . preparing motions and responses regarding case-wide discovery matters and other
       pretrial issues, and maintaining a document depository for all documents produced in MDL
       1203.
                 The PM C was also charged with establishing a Discovery Committee, which
       consisted of PMC members as well as additional lawyers representing plaintiffs in various
       state courts. . . . The PMC Discovery Committee coordinated and completed numerous
       depositions of defendants' corporate representatives, employees and generic experts. The
       court permitted the PMC and the co-chairs of the PMC Discovery Committee to assign work
       to other “common benefit” attorneys.

In re: Diet Drugs (Phentermine, Fenfluramine, Dexfenfluramine) Products Liability Litigation, 553 F.
Supp. 2d 442, 449-50 (E.D. Pa. 2008).

                                                    3
drug clients, more than $7.4 million. Dixon received the third largest settlement award, which

was more than $3.1 million.

¶5.    More than a year after the settlement of the plaintiffs’ cases against AHP, the trustee

of the MDL 1203 fund made a determination that one-third of all the sums deposited into the

MDL 1203 Fee and Cost Account should be returned to those who had contributed them

through a process approved by the MDL trustee’s office. Consequently, two percent of Lee’s

diet-drug clients’ $32 million settlement was returned to Lee. In allocating the refund, Lee

retained forty-five percent as his attorney’s fee and refunded each client a per capita share,

rather than a pro rata share, of the remaining fifty-five percent. This resulted in each of Lee’s

diet-drug clients receiving one-thirteenth of the refund instead of an amount based on a

percentage of the total settlement the client received. However, Lee no longer represented

Thompson and Dixon and they would not sign the necessary acknowledgment and consent

form; therefore, their refund was not sent to Lee for disbursement. The refunds allocated for

Thompson and Dixon still remain on deposit with the MDL 1203 Trustee.

¶6.    Thompson and Dixon subsequently filed the present lawsuit against Lee, claiming

breach of contract, tortious breach of contract, failure to properly refund the plaintiffs their

MDL fees, and that Lee is only entitled to be paid on a quantum meruit basis. Lee filed a

motion for summary judgment alleging that no genuine issue of material fact existed regarding

whether the plaintiffs had signed the retainer agreements and disbursement sheets authorizing

a forty-five percent contingency fee. The motion further alleges that no genuine issue of

material fact exists as to whether the plaintiffs were assessed the same amount of money for




                                               4
the MDL fees as Lee’s eleven other diet-drug clients. Lee argued he was entitled to judgment

as a matter of law and requested that the court grant summary judgment in his favor.

¶7.    Thompson and Dixon filed a response to Lee’s motion for summary judgment and

moved the trial court to grant partial summary judgment in their favor. The plaintiffs’ motion

alleged that Lee refused to produce original copies of the contingency-fee contract and

questions the genuineness and authenticity of the photocopy that was produced and the

circumstances surrounding its production. The motion further alleged that genuine issues of

material fact existed as evidenced by “substantial written documentation and sworn

testimony” as to whether Lee overcharged the plaintiffs for attorney’s fees. Finally, the

plaintiffs’ motion claimed that no genuine issue of material fact existed as to whether the

MDL fee refund was misappropriated by Lee. The plaintiffs requested the trial court to grant

partial summary judgment as to the MDL fee issue.

¶8.    The trial court entered a memorandum opinion and order granting partial summary

judgment to both parties. The trial court found that “upon signing the settlement disbursement

sheet, plaintiffs became aware and agreed that Lee was retaining [forty-five percent] of their

recoveries in attorney fees.” Relying on this Court’s holding in Turner v. Wakefield, 481 So.

2d 846, 848 (Miss. 1985), the trial court found that the plaintiffs had ratified the forty-five

percent paid to Lee as attorney’s fees and there existed no genuine issue of material fact with

respect to the breach of contract and tortious breach of contract claims. The trial court granted

summary judgment to Lee as to that issue. Because of this holding, the trial court also found

that payment to Lee in quantum meruit is not appropriate and summary judgment was granted

in favor of Lee on this claim, as well.


                                               5
¶9.    With regard to the MDL fees, the trial court found that, “[t]he MDL Agreement entered

into on behalf of his clients by Lee indicates that [six percent] of the settlement of each client

shall be deposited in the MDL Fund.” (emphasis added.)         The trial court further found that

certain federal MDL 1203 pretrial orders were applicable in the present matter and required

disbursement of the MDL refund on a pro rata basis.         Therefore, summary judgment was

granted to the plaintiffs as to this issue.

                                         DISCUSSION

¶10.   Lee appeals from the trial court’s decision and the plaintiffs cross-appeal. They raise

the following issues:

       I.      Whether the trial court erred in granting summary judgment to
               Thompson and Dixon regarding the MDL refund.

       II.     Whether the trial court lacked jurisdiction to enforce federal court
               orders.

       III.    Whether the trial court erred in granting summary judgment to Lee
               regarding the contingency fee.

¶11.   A trial court’s grant or denial of summary judgment is reviewed de novo. Daniels v.

GNB, 629 So. 2d 595, 599 (Miss. 1993) (citing Mantachie Natural Gas Dist. v. Miss. Valley

Gas Co., 594 So. 2d 1170, 1172 (Miss. 1992)). In reviewing the record, the court must

consider all the evidence in the light most favorable to the nonmoving party when deciding

to grant or deny summary judgment. Edmonds v. Williamson, 13 So. 3d 1283, 1287-88

(Miss. 2009) (citing United States Fid. & Guar. Co. v. Martin, 998 So. 2d 956, 962 (Miss.

2008)). Further, the “trial court's grant of summary judgment shall be affirmed ‘if the

pleadings, depositions, answers to interrogatories and admissions on file, together with the



                                                6
affidavits, if any, show that there is no genuine issue as to any material fact and that the

moving party is entitled to a judgment as a matter of law.’” Germany v. Denbury Onshore,

LLC, 984 So. 2d 270, 275 (Miss. 2008) (quoting Miss. R. Civ. P. 56(c)).

                                       I. MDL Refund

¶12.   Lee complains that the trial court incorrectly relied on three pretrial orders entered by

the United States District Court for the Eastern District of Pennsylvania, MDL 1203 Pre-Trial

Orders 467, 517, and 2152, in granting summary judgment to the plaintiffs on the issue of the

MDL fee refund. Lee alleges that these pretrial orders are inapplicable because no mechanism

exists to transfer a case from a Mississippi state court to a federal MDL court and because the

Circuit Court of Holmes County did not enter an order as required by the language of Pre-

Trial Order No. 467.

¶13.   In his opinion, the trial judge pointed out that Pre-Trial Order No. 467 “states that all

state court actions are eligible for state-federal coordination under the orders, provided that

the state court orders such coordination.” The trial court reviewed the orders and the

agreement entered into between Lee and the PMC of MDL 1203, and concluded that the

pretrial orders were applicable in the present matter. Because the trial court was of the

opinion that the orders were applicable, it held that the MDL Refund was to be administered

on a pro rata basis and granted summary judgment in favor of the plaintiffs on this issue.

       The MDL 1203 Pre-Trial Orders

¶14.   MDL 1203 Pre-Trial Order 467 established a system in which a certain percentage of

all MDL 1203 settlements would be sequestered so that the funds would be “available to

provide for reimbursement of costs and payment of attorneys’ fees to the Plaintiffs’

                                               7
Management Committee . . . to perform work for the benefit of plaintiffs in MDL 1203 and

in any state-court proceedings coordinated hereunder.” MDL 1203 Pre-Trial Order 467 (Feb.

10, 1999). The order further states, “All funds in the account will be held as funds subject to

the direction of the Court.” MDL 1203 Pre-Trial Order 467 (Feb. 10, 1999) (emphasis

added). “The Court” refers to the United States District Court for the Eastern District of

Pennsylvania, the court which issued the order.

¶15.   With regard to diet-drug cases in state courts, Pre-Trial Order 467 further states:

       Any action pending in any state court which relates to the personal injuries
       allegedly caused by [the diet drugs] is eligible for State-Federal coordination
       under the terms of this Order provided that the action is subject to an order
       entered by the Court having jurisdiction over the action which provides
       substantially as follows:

              a.     All state court actions subject to the state court order are
                     eligible for state-federal coordination under this Pretrial
                     Order entered in MDL 1203;

              b.     Before making any claim payment to any plaintiff, all
                     defendants in each action subject to the state court order,
                     shall deduct from such payment an amount equal to [six
                     percent] of the aggregate of the amount being paid and
                     any amounts to be paid in the future and shall pay such
                     sum for deposit into the MDL 1203 Fee and Cost Account
                     ...

              c.     The parties in each state-court action subject to the
                     state-court order are prohibited from using any of the
                     PMC’s or plaintiffs’ work product . . . for any purpose
                     other than the litigation ofactions pending in federal court
                     and actions pending in state courts which qualify for
                     state-federal coordination pursuant to the terms of this
                     PTO.

MDL 1203 Pre-Trial Order 467 (Feb. 10, 1999). Lee argues that since no such order was

entered by the Circuit Court of Holmes County, the Pre-Trial Orders are inapplicable.


                                              8
¶16.   MDL 1203 Pre-Trial Order 517 states that Pre-Trial Order 467 “is hereby extended to

all MDL No. 1203 civil actions, irrespective of the jurisdictions from which the actions were

transferred.” MDL 1203 Pre-Trial Order 517 (March 18, 1999). Pre-Trial Order 517 is

inapplicable because the underlying diet-drug suit was never transferred into or out of the

Eastern District of Pennsylvania, but rather Lee simply contracted with the PMC for the

“common benefit” discovery.

¶17.   MDL 1203 Pre-Trial Order 2152 sought to clarify Pre-Trial Orders 467 and 517. It

stated, “Defendants are required to withhold [nine percent]2 from the gross amount of each

Claim.” MDL 1203 Pre-Trial Order 2152 (Sept. 12, 2001) (emphasis added.) The order

further stated, “a plaintiff’s attorney is required to determine the amount owed to the attorney

under the terms of his or her retention agreement and reduce the amount owed under the

retention agreement by the amount withheld under the [nine-percent] assessment. The

plaintiff’s recovery shall not be affected by the [nine-percent] assessment.” MDL Pre-Trial

Order 2152 (Sept. 12, 2001). The trial court found that Pre-Trial Order 2152's language

required that the MDL fee be taken from each claim, and should therefore be refunded to each

claim on a pro rata basis.

¶18.   We find that the MDL 1203 Pre-Trial Orders 467 and 2152 are applicable in the

present matter. In his motion for summary judgment, Lee admits:

       In order to successfully and economically prosecute his diet drug case, [Lee]
       participated in the Multi District Litigation (MDL) Common Benefit Fund in
       which all participating parties agreed to pay [six percent] of their recovery as



        2
        A nine-percent fee was charged to MDL 1203 cases which were being litigated in the federal court
system. A six-percent fee was charged to MDL 1203 cases which were state-federal coordinated cases.

                                                  9
       a fee for use of expert witnesses, litigation materials and other documents
       necessary to litigate diet drug claims.

Lee argued at the hearing and now on appeal that no order existed in the underlying action

subjecting the diet-drug litigation in the Holmes County Circuit Court to the federal MDL

orders. The plaintiffs did not provide such an order in response, and none can be found in the

record. However, the trial court reviewed the contract between Lee and the PMC of MDL

1203 and the language of the Pre-Trial Orders themselves, and determined the orders to be

applicable. The trial court was correct in this determination.

¶19.   MDL 1203 Pre-Trial Order 467 specifically states, “The Court shall establish an

insured, interest bearing escrow account to receive and disburse funds as provided in this

Order. The Court will, by future Order, designate an escrow agent to manage the account.

All funds in the account will be held as funds subject to the direction of the Court.” MDL

1203 Pre-Trial Order 467 ¶ 5 (Feb. 10, 1999). Lee admits that he willingly participated in the

MDL Common Benefit Fund, and therefore he voluntarily subjected himself to the orders of

the United States District Court for the Eastern District of Pennsylvania in regard to the funds

he placed in the MDL account. Therefore, the Pre-Trial Orders are applicable.

¶20.   Because the Pre-Trial Orders are applicable, the trial court was correct in granting

summary judgment to the plaintiffs as to the issue of whether the MDL refund was to be

distributed on a pro rata basis. MDL 1203 Pre-Trial Order 2152 provides specific instructions

as to how the MDL fee is to be paid. The percentage owed to the MDL Fund is to be

deducted entirely from the attorney’s fees, not the client’s recovery. The order provides the

following example:



                                              10
       Assumptions: Jane Doe has entered into a contingency fee agreement with her
       attorney that provides for a forty percent fee to be calculated after the deduction
       of expenses from a gross settlement or judgment amount. Jane Doe has
       accepted an offer to settle her MDL 1203 case for $100,000.00.

       Distribution:
              $100,000.00              Gross Settlement Amount
              - $9,000.00              [Nine Percent] Assessment3 (Deducted By AHP)4
               $91,000.00              Settlement Payment to Jane Doe’s Attorney

                $91,000.00             Settlement Payment to Jane Doe’s Attorney
               - $5,000.00             Litigation Expenses
                $86,000.00             Net Settlement Recovery

                 $86,000.00            Net Settlement Recovery
               - $29,000.00            Contingency Fee After Deduction
                                       of [Nine Percent] Assessment
                                       ($95,000.00 x 40% = $38,000.00 - $9,000.00)

                $57,000.00             Balance to Client

¶21.   Lee argued in his motion for summary judgment and now on appeal that “each of

[Lee’s thirteen] diet-drug clients paid an equal amount of the Common Benefit Fund because

each received equal benefits from the funds. Thus, each paid [one-thirteenth] of the total

amount.” Lee further argued, “Neither Thompson nor Dixon paid into the MDL Fund based

upon the amount of their individual settlements and are not entitled to refunds based upon the

amounts of their individual settlement amounts.” However, Lee’s argument is mathematically

illogical because the assessment was a percentage, rather than a specific dollar amount. Each




        3
         The example given was a case in the federal court system, in which the charge was nine percent.
The state-federal coordinated cases were assessed only six percent of their settlement as the MDL fee.
Regardless, the formula would work in the same manner.
        4
        MDL 1203 Pre-Trial Order 467 provided that the defendants in the diet-drug litigation (American
Home Products) would send nine percent of the settlement amount (or six percent where applicable) directly
to the MDL fund prior to distributing the remaining settlement balance to the plaintiffs.

                                                   11
client cannot contribute the same amount when the assessment is a percent of their recovery

unless each client recovers the same amount.

¶22.   Based on the requirements of Pre-Trial Order 2152, as evidenced by the above

example, the entire six-percent MDL fee was to be deducted from Lee’s attorney’s fees.

Payments to all of Lee’s thirteen diet-drug clients should have been made in this manner. Had

that been done, the entire two-percent refund would have belonged to Lee – as the entirety of

the MDL 1203 fee would have been deducted entirely from his attorney’s fees. Therefore,

the trial court was correct in granting summary judgment to the plaintiffs as to the MDL

refunds because there is no genuine issue of material fact that such payments should have

been made on a pro rata basis. However, this issue must be remanded to the trial court to

determine if the settlement was distributed in accordance with MDL 1203 Pre-Trial Order

2152, and if not, to order such distribution.

                                       II. Jurisdiction

¶23.   Lee questions the trial court’s jurisdiction to hear this case and further complains that

the trial court improperly granted full faith and credit to the order of a foreign court in

granting the plaintiffs summary judgment on this issue of the MDL fee refund. Lee cites In

re: Zyprexia Products Liability Litigation, 467 F. Supp. 2d 256, 268 (E.D.N.Y. 2006), and

In re: Showa Denko K.K. L-Tryptophan Products Liability Litigation, 953 F.2d 162 (4th Cir.

1992), as authority for the proposition that the trial court lacked jurisdiction to enforce the

federal orders. Lee also claims Thompson and Dixon did not follow the procedure established

by the Uniform Enforcement of Foreign Judgments Act, Mississippi Code Sections 11-7-301




                                                12
through 11-7-309, in order to have the MDL 1203 Pre-Trial Orders enforced in the present

action. See Miss. Code Ann. § § 11-7-301 to 11-7-309 (Rev. 2004.)

¶24.   In re: Zyprexia and In re: Showa Denko K.K. are both federal cases reviewing pre-

trial orders in unrelated Multi-District Litigation matters. In re: Zyprexia is a trial court

ruling on a motion by the Plaintiffs’ Steering Committee (“PSC”) of an MDL matter in the

United States District Court for the Eastern District of New York. The PSC sought funding

partly through requiring a portion of every recovery paid to plaintiffs’ attorneys in state courts

where the state plaintiff’s attorney also represented federal plaintiffs to be paid into a common

benefit fund. The trial court ruled that “such compulsion would be inappropriate.” In re:

Zyprexia, 467 F. Supp. 2d at 268. However, those facts are distinguishable from the present

matter. The order at issue in In re: Zyprexia would have compelled any attorney who

represented clients in both state and federal courts involuntarily to pay a portion of his or her

fees into the common-benefit fund. In the present matter, Lee purposefully and willfully

availed himself of the common-benefit discovery and agreed to pay into the MDL fund in

exchange. Therefore, the In re: Zyprexia holding is inapplicable.

¶25.   In re: Showa Denko K.K. is a federal appellate-court decision which struck portions

of a trial court order providing funding for the PSC in that particular MDL. In re: Showa

Denko K.K., 953 F. 2d at 162. The portions which were struck required payment from

plaintiffs’ attorneys in state cases in which any MDL defendant was a party or payor. In re:

Showa Denko K.K., 953 F.2d at 164. The United States Court of Appeals for the Fourth

Circuit held that the portion of the order which “compels contributions from plaintiffs in state

. . . litigation who are not before the court” to have an “impermissible reach.” Id. at 166. The

                                               13
court held that those portions must be stricken from the order because they were “improperly

broad.” Id. Again, the present case is distinguishable in that the order at issue in In re:

Showa Dinko K.K. compelled payment from attorneys who had not purposefully and willfully

availed themselves of the benefit of the MDL discovery and agreed to pay compensation in

exchange for such benefit.

¶26.   Lee has clearly stated that in order “to successfully and economically prosecute his diet

drug case, [Lee] participated in the [MDL] Common Benefit Fund in which all participating

parties agreed to pay [six percent] of their recovery as a fee.” Lee purposefully and willfully

sought the benefit of the MDL discovery and agreed to pay into the Common Benefit Fund

in exchange. Therefore, Lee’s argument that In re: Zyprexia and In re: Showa Denko K.K.

bar this Court from enforcing the federal court orders to which he willingly submitted himself

is without merit.

¶27.   Further, Lee claims the plaintiffs, Thompson and Dixon, should have followed the

procedure laid out in the Uniform Enforcement of Foreign Judgments Act, Mississippi Code

Sections 11-7-301 through 11-7-309, in order the have the MDL 1203 Pre-Trial Orders

enforced in the Circuit Court of Holmes County. However, the procedure set forth in the

Uniform Enforcement of Foreign Judgments Act is applicable to final judgments upon which

collection can be made - - not pretrial orders. This issue also is without merit.

                                   III. Contingency Fee

¶28.   Finally, on cross-appeal, Thompson and Dixon allege the trial court erred in granting

summary judgment to Lee regarding the disputed contingency fee. Thompson and Dixon

claim they signed contingency-fee agreements that stipulated that Lee would earn forty

                                              14
percent of their settlement, but that Lee instead charged them forty-five percent. The trial

court ruled that the plaintiffs had ratified Lee retaining forty-five percent of the settlement by

accepting their settlement funds with knowledge that Lee was retaining forty-five percent of

their recoveries. The trial court concluded that such knowledge was imparted to the plaintiffs

when they signed the settlement disbursement sheet which indicated that Lee would be paid

forty-five percent of the settlement. Therefore, summary judgment was granted in Lee’s favor

as to this issue.

¶29.    As evidence that a genuine issue of material fact exists as to the amount of the agreed-

upon contingency fee, the plaintiffs point to the following: conflicting testimony regarding

whether the contingency-fee contracts provided for attorney’s fees of forty-five percent or

forty percent of the settlement, Lee’s apparent inability to produce original contingency-fee

contracts, the disputed nature of the photocopied contract’s authenticity, and the alleged

intimidation and coercion under which Thompson and Dixon signed their settlement

disbursement statements. Furthermore, Dixon testified at her deposition that she had

discussed the attorney-fee issue with four of the other diet-drug plaintiffs, and they had agreed

that their original contingency-fee contract was for forty percent, but when they went to sign

their settlement disbursement sheet the fee was forty-five percent. However, one of the four

later recanted her story.

¶30.   Thompson and Dixon further claim they had tremendous trouble obtaining and copying

their client file from Lee. The record contains significant documentation as to the steps they

took to obtain the client file. When the plaintiffs finally received their files to copy, neither

an original nor a copy of the contingency-fee contract was located in the file. Copies of the


                                               15
retainer agreements stating the contingency fee was forty-five percent were eventually

produced. However, the plaintiffs question their authenticity and claim their signatures appear

to have been cut and pasted onto the documents.

¶31.   Further, the plaintiffs claim in their briefs that they were coerced into signing the

settlement-disbursement sheets at the time they originally received their portion of the

settlement. However, Thompson testified in her deposition that when she went to pick up her

settlement check, Lee explained, “this is what your settlement amount was. This is my

attorney fees.” She went on to testify that the reason she signed the settlement disbursement

sheet to receive her check – despite the questions she had regarding the attorney’s fees – was

that “it really didn’t matter. . . when I did get what he told me I was going to get, I was going

to have more money than I would ever spend in my life.” Thompson testified that Lee only

spoke harshly and used profanity when she questioned him about the MDL refund.

¶32.   Dixon also testified at her deposition that she began to question the contingency fee

when she heard “rumors” that the contingency fee between Lee and his diet-drug clients was

forty-five percent. Dixon then said, “I called Sharon Lee[, Lee’s wife,] and asked her about

the [forty-five] percent. She told me it went up. I said, ‘How can it just go up?’ She said

because no other attorney was settling the fen-phen cases for [forty] percent.”

¶33.   When asked why she signed the settlement-disbursement sheet that clearly stated she

was paying forty-five percent in attorney’s fees, Dixon answered, “Lee told me if we didn’t

sign, that we was [sic] gonna [sic] have to pay him and still find another attorney. And who

was gonna [sic] start all over when we done got to this point?” Dixon testified that she did




                                               16
not confront Lee about the alleged increase in attorney’s fees because she already had asked

Sharon Lee about the issue on the telephone, and been told the fees “went up.”

¶34.   Thompson and Dixon cite this Court’s recent decision in Waggoner v. Williamson, 8

So. 3d 147 (Miss. 2009), for the proposition that settling a claim does not waive the client’s

right to pursue a suit against the attorney. It is true that this Court does not accept the

proposition that “because the plaintiffs accepted the settlement funds, that they waived any

right to sue for malpractice” Id. at 156 (quoting Channel v. Loyacono, 954 So. 2d 415, 426

(Miss. 2007)), however, that is not the ruling the trial court made in the present matter. The

trial court held that in signing the settlement-disbursement sheet, the plaintiffs became aware

that Lee was retaining forty-five percent of their recovery as attorney’s fees and agreed to let

him do so. The trial court based its ruling on this Court’s holding in Turner v. Wakefield, 481

So. 2d 846, 848 (Miss. 1985), wherein this Court adopted that appellants’ reasoning:

       Where one is induced through false and fraudulent representations to enter into
       an agreement upon discovery thereof, he has an election to either rescind, in
       which event he must tender back that which he has received, or he may affirm
       the agreement, and maintain his action in damages for deceit, but his election
       must be promptly made, and, and when once made, is final. If one elects to
       affirm the agreement, after full knowledge with the truth respecting the false
       and fraudulent representation, and thereafter continues to carry it out and
       receive its benefits, he may not thereafter maintain an action in damages for
       deceit, because this would constitute a ratification of the agreement and
       condemnation of the fraud; otherwise one might, with knowledge of fraud,
       speculate upon the advantages or disadvantages of an agreement, receive its
       benefits, and thereafter repudiate all its obligations.

Id. (citing Stoner v. Marshall, 145 Colo. 352, 358 P.2d 1021 (1961)). The Court restated this

rule by saying, “assuming the fact of fraud, a contract obligation obtained by fraudulent

representation is not void, but voidable. Upon discovery thereof, the one defrauded must act



                                              17
promptly and finally to repudiate the agreement; however, a continuance to ratify the contract

terms constitutes a waiver.” Id. at 848-49.

¶35. However, distinguishing the present case from the rule set forth in Turner are the

allegations of coercion. “The law will presume that the contract was freely entered into by

the parties without coercion or overreaching.” Singer v. Tatum, 251 Miss. 661, 691, 171 So.

2d 134, 148 (1965). Both plaintiffs allege Lee coerced them into signing the disbursement

sheets which stated Lee’s fee was forty-five percent, because Lee stated that their failure to

do so would delay their compensation or prevent it all together. Both Thompson and Dixon

allege that their attorney – who owed them all of the fiduciary duties which are part of the

attorney-client relationship – “strong-armed” them into signing the disbursement sheets.

¶36.   This matter must be remanded to the trial court for the finder of fact to determine if

such coercion was present at the time the disbursement sheets were signed, keeping in mind

the fiduciary relationship between a lawyer and his client. If such coercion is found, the

Turner rule will be inapplicable. It will be a question for the jury as to whether Thompson

and Dixon originally entered a contract with Lee to pay him forty percent or forty-five percent

of their recovery. Therefore, the trial court is reversed as to this issue.

                                       CONCLUSION

¶37.   The trial court did not err in granting summary judgment to the plaintiffs on the issue

of the MDL refund. This case must be remanded, however, to determine if the MDL fees

were paid in accordance with MDL 1203 Pre-Trial Order 2152, and if not, to order such

distribution. The trial court erred in granting summary judgment to the defendant as to the

breach-of-contract claim, and the matter must also be remanded on this issue. Further,

                                               18
because the breach-of-contract claim has been remanded, so must the claims for tortious

breach of contract, fraud, and quantum meruit, as they are contingent on the determination of

the breach-of-contract claim. Therefore, the trial court’s judgment is affirmed on direct

appeal, reversed on cross-appeal, and this case is remanded to the trial court for further

proceedings consistent with this opinion.

¶38. ON DIRECT APPEAL: AFFIRMED AND REMANDED.                                  ON CROSS-
APPEAL: REVERSED AND REMANDED.

    WALLER, C.J., CARLSON, P.J., DICKINSON, RANDOLPH, LAMAR,
KITCHENS AND CHANDLER, JJ., CONCUR.         GRAVES, P.J., NOT
PARTICIPATING.




                                             19
